Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gi‐Jun Sung
Observed names:
G.J. Sung,
Gi-Jun Sung
Institution:
Korea Research Institute for Human Settlements
Observed institutions:
Asan Medical Center,
University of Ulsan,
Korea Research Institute for Human Settlements,
Michigan State University
ORCID:
0000-0002-2346-2449
Observed ORCID:
0000-0002-2346-2449
OpenAlex ID:
A5086752664
Delphinidin induces apoptosis via cleaved HDAC3-mediated p53 acetylation and oligomerization in prostate cancer cells
2016
·
Mi-Hyeon Jeong
, Hyeonseok Ko
, et al.
·
Oncotarget
·
72
PDF
Delphinidin sensitizes prostate cancer cells to TRAIL-induced apoptosis, by inducing DR5 and causing caspase-mediated HDAC3 cleavage
2015
·
Hyeonseok Ko
, Mi-Hyeon Jeong
, et al.
·
Oncotarget
·
52
PDF
DNAJB1 destabilizes PDCD5 to suppress p53-mediated apoptosis
2014
·
Xiandan Cui
, Hyo-Kyoung Choi
, et al.
·
Cancer Letters
·
52
Inhibition of TFEB oligomerization by co‐treatment of melatonin with vorinostat promotes the therapeutic sensitivity in glioblastoma and glioma stem cells
2019
·
Gi‐Jun Sung
, Sung‐Hak Kim
, et al.
·
Journal of Pineal Research
·
45
Epigenetic regulation of p62/SQSTM1 overcomes the radioresistance of head and neck cancer cells via autophagy-dependent senescence induction
2021
·
Myungjin Lee
, Hae Yun Nam
, et al.
·
Cell Death and Disease
·
41
PDF
TFEB Supports Pancreatic Cancer Growth through the Transcriptional Regulation of Glutaminase
2021
·
Ji Hye Kim
, Jinyoung Lee
, et al.
·
Cancers
·
38
PDF
Small-molecule inhibitors of histone deacetylase improve CRISPR-based adenine base editing
2021
·
Ha Rim Shin
, Ji-Eun See
, et al.
·
Nucleic Acids Research
·
29
PDF
EGFR–c-Src-Mediated HDAC3 Phosphorylation Exacerbates Invasion of Breast Cancer Cells
2019
·
Sung-Min Kwak
, Jaesung Seo
, et al.
·
Cells
·
26
PDF
Novel TGF‐β1 inhibitor antagonizes TGF‐β1‐induced epithelial‐mesenchymal transition in human A549 lung cancer cells
2018
·
Ji‐Hoon Jeong
, Hae Jin Jang
, et al.
·
Journal of Cellular Biochemistry
·
24
SIRT1 plays an important role in implantation and decidualization during mouse early pregnancy
2022
·
Yeon Jeong Hwang
, Gi-Jun Sung
, et al.
·
Biology of Reproduction
·
23
Targeting CPT1A enhances metabolic therapy in human melanoma cells with the BRAF V600E mutation
2016
·
Gi-Jun Sung
, Hyo-Kyoung Choi
, et al.
·
The International Journal of Biochemistry & Cell Biology
·
22
Antiobesity and Cholesterol-Lowering Effects of Dendropanax morbifera Water Extracts in Mouse 3T3-L1 Cells
2018
·
Ji-Hye Song
, Hee-Bum Kang
, et al.
·
Journal of Medicinal Food
·
21
Serine/threonine kinase 31 promotes PDCD5‐mediated apoptosis in p53‐dependent human colon cancer cells
2018
·
Sungmin Kwak
, Seung‐Hyun Lee
, et al.
·
Journal of Cellular Physiology
·
14
TNFα Enhances Tamoxifen Sensitivity through Dissociation of ERα-p53-NCOR1 Complexes in ERα-Positive Breast Cancer
2021
·
Hyunhee Kim
, Seung-Ho Park
, et al.
·
Cancers
·
6
PDF
A New TGF-β1 Inhibitor, CTI-82, Antagonizes Epithelial–Mesenchymal Transition through Inhibition of Phospho-SMAD2/3 and Phospho-ERK
2020
·
Ji-Hoon Jeong
, Hyunhee Kim
, et al.
·
Biology
·
4
PDF
PHI-101, a Novel FLT3 TKI, Shows Clinical Efficacy in Relapsed/Refractory FLT3-Mutated AML
2024
·
Dong-Yeop Shin
, Sung-Soo Yoon
, et al.
·
Blood
·
3
PHI-101 As a Potent Next-Generation FLT3 Inhibitor, Overcome Resistances in Previously Treated Patients with FLT3-ITD or TKD Acute Myeloid Leukemia: Results of a Phase Ia/Ib Clinical Trial
2023
·
Sung-Soo Yoon
, Dongyeop Shin
, et al.
·
Blood
·
2
PHI-101: a novel FLT3 inhibitor with potent activity against the F691L gatekeeper resistance mutation
2026
·
Marina Mitrou
, Li Li
, et al.
·
Leukemia
PDF
PHI-501, a dual inhibitor of RAF and DDR1/2, overcomes MAPK drug resistance in Melanoma
2026
·
Sue Min Kim
, Sungmin Cho
, et al.
·
Cancer Cell International
Abstract 4371: PHI-501 as a potent pan-RAF/DDRs inhibitor suppresses lung cancer cell proliferation and overcomes KRAS G12C inhibitor resistance
2025
·
An-Na Moon
, Ji Young Kim
, et al.
·
Cancer Research
223 (PB211): PHI-101 synergizes with chemotherapy and PARP inhibitors in preclinical models of ovarian cancer
2024
·
G.J. Sung
, H.S. Hwang
, et al.
·
European Journal of Cancer
Abstract 4657: PHI-501 is a novel potent next-generation pan-RAF/DDRs inhibitor, and overcomes resistance to RAF or MEK inhibitor in melanoma via dual inhibition of RAF and DDR1/2 signaling
2024
·
Sue Min Kim
, Sungmin Cho
, et al.
·
Cancer Research
Abstract 7153: PHI-101 synergizes with chemotherapy and venetoclax in preclinical models of acute myeloid leukemia
2024
·
Hee-sun Hwang
, Gi-Jun Sung
, et al.
·
Cancer Research
Evaluation of Synergistic Anti-Leukemic Efficacy of PHI-101 in Preclinical Model of FLT3-ITD Acute Myeloid Leukemia
2023
·
Gi-Jun Sung
, Kyung-Ah Kim
, et al.
·
Blood
PDF
Show more works
View as search
Works count:
24
Citation count:
474
H-index:
13
I10-index:
13
Year
Topic
Type